Filing Details

Accession Number:
0001140361-15-045654
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-28 14:20:04
Reporting Period:
2015-12-23
Filing Date:
2015-12-28
Accepted Time:
2015-12-28 14:20:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380187 Daniel Abdun-Nabi 400 Professional Dr, Suite 400
Gaithersburg MD 20879
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-23 40,354 $18.90 225,722 No 4 M Direct
Common Stock Disposition 2015-12-23 40,354 $38.99 185,368 No 4 S Direct
Common Stock Acquisiton 2015-12-24 22,855 $18.90 208,223 No 4 M Direct
Common Stock Disposition 2015-12-24 22,855 $39.17 185,368 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2015-12-23 40,354 $0.00 40,354 $18.90
Common Stock Stock Option Disposition 2015-12-24 22,855 $0.00 22,855 $18.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,855 2019-03-09 No 4 M Direct
0 2019-03-09 No 4 M Direct
Footnotes
  1. Consists of an option granted under the company's stock incentive plan on March 10, 2009.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.79 to $39.11, inclusive.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.99 to $39.48, inclusive.
  5. The option vested in three equal installments in March 2010, 2011 and 2012.